|
Dr. Kerstin Waterloh has over ten years experience consulting to the healthcare industry. She is well versed in business planning, evaluation and review, production and market strategy development and optimization, as well as revenue forecasting for valuation determination. Dr. Waterloh’s prior experience includes eight years with The Wilkerson Group in the UK and Europe where she worked on global market strategy projects for numerous healthcare clients. Immediately prior to joining Easton Associates, she spent four years leading the Life Sciences Investment portfolio of IKB Private Equity, where she helped finance both early stage and mid-size life sciences companies. Dr. Waterloh holds a graduate and Ph.D. degree in molecular biology, as well as an MBA. She is fluent in several languages, holds a seat on the boards of Cardion AG, palm Microsystems AG and Cellnix AG, and has published several articles on pharmaceutical strategy, as well as reviews of the pharmaceutical and chemical industries. | 